Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2006-05-09
2006-05-09
Ketter, James (Department: 1636)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C530S395000, C514S002600
Reexamination Certificate
active
07041794
ABSTRACT:
The present invention relates to new polynucleotides deriving from the nucleotide sequence of the EPO gene and comprising new SNPs, new polypeptides derived from the natural EPO protein and comprising at least one mutation caused by the SNPs of the invention as well as their therapeutic uses.
REFERENCES:
patent: 4414150 (1983-11-01), Goeddel
patent: 4615974 (1986-10-01), Kingsman et al.
patent: 4678756 (1987-07-01), Parks
patent: 4748233 (1988-05-01), Sloma
patent: 4751287 (1988-06-01), Berzin et al.
patent: 4780530 (1988-10-01), Teraoka et al.
patent: 4801685 (1989-01-01), Goeddel et al.
patent: 4810645 (1989-03-01), Goeddel et al.
patent: 4816566 (1989-03-01), DeChiara et al.
patent: 4820638 (1989-04-01), Swetly et al.
patent: 4885166 (1989-12-01), Meyer et al.
patent: 4917887 (1990-04-01), Hauptmann et al.
patent: 5723125 (1998-03-01), Chang et al.
patent: 6555343 (2003-04-01), DeSauvage et al.
patent: 2002/0037841 (2002-03-01), Papadimitriou
patent: 0 032 134 (1981-01-01), None
patent: 0 051 873 (1981-11-01), None
patent: 0 062 971 (1982-03-01), None
patent: 0 073 635 (1982-08-01), None
patent: 0 128 467 (1984-05-01), None
patent: 0 141 484 (1984-06-01), None
patent: 0 194 006 (1986-01-01), None
patent: 0 236 920 (1987-03-01), None
patent: 0 553 494 (1992-12-01), None
patent: 2 079 291 (1981-07-01), None
patent: WO 83/02458 (1983-01-01), None
patent: WO 83/02459 (1983-01-01), None
patent: WO 83/04053 (1983-04-01), None
patent: WO9505465 (1995-02-01), None
patent: WO 01/11056 (2000-08-01), None
Chem, Y et al. Structural role of amino acids 99-110 in recombinant erythropoietin. (1991), vol. 202, pp. 225-229.
Lee, N., et al., “Interferon-α2Variants in the Human Genome,” Journal of Interferon and Cytokine Research 15:341-349 (1995). XP-001016231.
Kita, M., et al., “Determination of Interferon-α2Allele Composition in the Geneomic DNA from Healthy Voulunteers and Leukemic Patients in Japan,” Journal of Interferon and Cytokine Research 17:135-140 (1997) XP-001016233.
Piehler, J., et al., “Fast Transient Cytokine-Receptor Interactions Monitored in Real Time by Reflectometric Interference Spectroscopy,” Analytical Biochemistry 289, 173-186 (2001), XP-002185474.
Piehler, J., et al., “Mutational and Structural Analysis of the Binding Interface Between Type 1 Interferons and their Receptor Ifnar2,” J. Mol. Biol. (1999) 294, 223-237, XP-002185475.
Brown Rudnick Berlack & Israels LLP
Garvey Tara L.
Genodyssee
Hofer Mark A.
LandOfFree
Polynucleotides and polypeptides of the erythropoietin gene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polynucleotides and polypeptides of the erythropoietin gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polynucleotides and polypeptides of the erythropoietin gene will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3633936